Organizer
Separation Science
Separation Science
Separation Science is the leading online resource for methods, applications, troubleshooting and training in chromatography and mass spectrometry.
Tags
LC/MS
OMICS
LinkedIn Logo

The Neurolipid Atlas Project

RECORD | Already taken place Th, 21.3.2024
Learn how a quantitative shotgun lipidomics solution is used for establishing a lipidomics atlas, and mapping cell and disease-specific lipid changes.
Go to the webinar
SCIEX: The Neurolipid Atlas Project
SCIEX: The Neurolipid Atlas Project

By attending this presentation, you will:

  • Learn about the quantitative shotgun lipidomics platform and its application
  • Find out about necessary hardware and software, and address visualization and application
  • See how this particularly evolves around the Neurolipid Atlas Project and drug development
Event Overview

New evidence from genetic, epidemiology, and cell biology data suggests that lipid and cholesterol metabolism play a role in several neurodegenerative diseases. Despite this, the study of lipid biology remains limited, and there are challenges in applying lipidomic techniques to human tissues. The Neurolipid Atlas Project seeks to examine the lipidome of human iPSC-derived neurons and glia, which have been gene-edited for specific disease variants. The objective is to establish the initial mapping of changes in the human lipidome linked to neurodegenerative diseases, focusing on disease-specific, genotype-specific, and cell type-specific changes.

This webinar will discuss the application of a quantitative shotgun lipidomics platform as a key technology for establishing a lipidomics atlas and mapping cell and disease-specific lipid changes.

What you need to know:

Date: 21 March, 2024

Start times:

Broadcast #1: 9 am GMT (London/Lisbon) / 10 am CET (Paris/Berlin) / 2:30 pm IST (New Delhi)

Broadcast #2: 2 pm GMT (London/Lisbon) / 3 pm CET (Paris/Berlin)

Duration: Approximately 60 minutes

Presenter: Martin Giera (Head of Metabolomics Group, Leiden University Medical Center, The Netherlands)

Martin Giera, Ph.D., studied pharmacy in Heidelberg and Munich. Martin was a visiting scientist at Harvard Medical School and the Scripps Research Institute. Martin is head of the metabolomics group at the Leiden University Medical Center. He is involved in several multi-national consortia and a member of several editorial boards, and was the chairman of the interdisciplinary committee at FWO. Martin has a keen interest in metabolomics technology, drug development, and biochemistry. He has published more than 175 scientific publications and books.

Separation Science
LinkedIn Logo
 

Related content

Comprehensive and Robust Analysis of Ultrashort- to Long-Chain PFAS, PAE, OPE, and PAH

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies, Plasmion
Industries
Environmental

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike